Skip to main content
Clinical Trials/NCT01698229
NCT01698229
Terminated
N/A

Collection of Cerebrospinal Fluid in Healthy Children

Weill Medical College of Cornell University1 site in 1 country32 target enrollmentDecember 2011

Overview

Phase
N/A
Intervention
Not specified
Conditions
Late Infantile Neuronal Ceroid Lipofuscinosis
Sponsor
Weill Medical College of Cornell University
Enrollment
32
Locations
1
Primary Endpoint
Cerebrospinal fluid (CSF)
Status
Terminated
Last Updated
10 years ago

Overview

Brief Summary

The purpose of this study is to obtain cerebrospinal fluid from healthy children already undergoing a lumbar puncture procedure at New York Presbyterian Hospital, to act as healthy controls when compared to children with late infantile neuronal ceroid lipofuscinosis (LINCL), a fatal neurodegenerative disease.

Detailed Description

obtain cerebrospinal fluid from healthy children already undergoing a lumbar puncture procedure at New York Presbyterian Hospital, to act as healthy controls when compared to children with late infantile neuronal ceroid lipofuscinosis (LINCL), a fatal neurodegenerative disease.

Registry
clinicaltrials.gov
Start Date
December 2011
End Date
December 2015
Last Updated
10 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Males and females, ages 2 yrs to 8 yrs
  • Children already undergoing a lumbar puncture procedure for clinical or diagnostic purposes

Exclusion Criteria

  • Presence of any significant neurological diseases, as judged by the co-investigators
  • Presence of any significant medical conditions including cancer

Outcomes

Primary Outcomes

Cerebrospinal fluid (CSF)

Time Frame: 1 time point (once)

The primary study endpoint is the metabolic profiling of 32 samples of cerebrospinal fluid from healthy subjects, in comparison to 32 samples of CSF from children with LINCL, to determine whether there are biomarkers found in the cerebrospinal fluid that are associated with LINCL.

Study Sites (1)

Loading locations...

Similar Trials

Completed
N/A
Identification of Cerebrospinal Fluid With Injeq IQ-Needle During Paediatric Lumbar PuncturePediatric Lumbar Puncture
NCT02792660Injeq Ltd40
Completed
N/A
Cerebrospinal Fluid RepositoryAmyotrophic Lateral SclerosisCerebrospinal FluidNeurodegenerative DiseaseMotor Neuron Disease
NCT00714636Drexel University College of Medicine11
Completed
N/A
Collection and Study of Cerebrospinal Fluid in Patients With Hunter SyndromeHunter Syndrome
NCT01449240Shire10
Recruiting
N/A
Collection of cerebrospinal fluid and performing skin biopsies for obtaining fibroblasts for studies at the DZNEeurodegenerative healthy subjects (healthy controls)G30.0G30.1G30.8G30.9G20G21G22G31.82G23.1G11.1G11.0G11.2G11.3G11.4G11.8G11.9G12.2G12.0G12.1I68.0Alzheimer disease with early onsetAlzheimer disease with late onsetOther Alzheimer diseaseAlzheimer disease, unspecifiedParkinson diseaseSecondary parkinsonismParkinsonism in diseases classified elsewhereProgressive supranuclear ophthalmoplegia [Steele-Richardson-Olszewski]Early-onset cerebellar ataxiaCongenital nonprogressive ataxiaLate-onset cerebellar ataxiaCerebellar ataxia with defective DNA repairHereditary spastic paraplegiaOther hereditary ataxiasHereditary ataxia, unspecifiedMotor neuron diseaseInfantile spinal muscular atrophy, type I [Werdnig-Hoffman]Other inherited spinal muscular atrophyCerebral amyloid angiopathy
DRKS00008308Deutsches Zentrum für Neurodegenerative Erkrankungen e.V. (DZNE)
Completed
N/A
Blood and Cerebrospinal Fluid for Pediatric Brain Tumor ResearchHydrocephalus
NCT01556178Ann & Robert H Lurie Children's Hospital of Chicago5